Elacestrant shows improved PFS in patients with ER-positive/HER2-negative metastatic breast cancer ecancer 3:24 1 year ago 385 Скачать Далее
Elacestrant: A New Weapon Against Advanced Estrogen Receptor-Positive Breast Cancer Pharmacology Insights 2:37 4 months ago 143 Скачать Далее
Update of EMERALD by duration of CDK4/6i in metastatic setting: elacestrant v SoC in ER+/HER2- mBC VJOncology 0:46 1 year ago 291 Скачать Далее
EMERALD: elacestrant vs. SOC for patients with ER+ HER2- metastatic breast cancer VJOncology 2:03 2 years ago 1 656 Скачать Далее
Assessing elacestrant in ctDNA-positive patients with ER+ breast cancer VJOncology 3:01 2 years ago 213 Скачать Далее
Elacestrant significantly prolongs PFS for ER+/HER2- metastatic BC without prior chemotherapy pts ecancer 2:06 2 years ago 712 Скачать Далее
EMERALD: elacestrant vs physicians choice in ER+/HER2- breast cancer VJOncology 1:27 2 years ago 759 Скачать Далее
GS2-02: "Elacestrant, an oral selective estrogen receptor degrader (SERD), vs investigator’s..." San Antonio Breast Cancer Symposium 20:37 1 year ago 628 Скачать Далее
EMERALD lead to the Elacestrant FDA Approval - OncBrothers in discussion w/ Dr. Virginia Kaklamani OncBrothers: Practice-Changing Cancer Discussions 17:11 1 year ago 533 Скачать Далее
EMERALD Study lead to the Elacestrant FDA Approval - OncBrothers in discussion w/ Dr. Aditya Bardia OncBrothers: Practice-Changing Cancer Discussions 16:10 1 year ago 890 Скачать Далее
ER+ metastatic breast cancer: Elacestrant and beyond COR2ED The Heart of Medical Education 5:30 5 months ago 119 Скачать Далее
Overview of Clinical Data of SERDs & Their Place in Treatment Landscape COR2ED The Heart of Medical Education 18:40 11 months ago 3 437 Скачать Далее
Orserdu tablets how to use: Uses, Dosage, Side Effects, Contraindications Pharmacy Assistant 3:00 1 year ago 278 Скачать Далее
Window of opportunity ELIPSE trial: elacestrant in postmenopausal women with ER+HER2-/ early BC VJOncology 2:29 1 year ago 160 Скачать Далее
Breast Cancer Breakthroughs: Dr. Donald McDonnell explains how elacestrant was discovered in his lab Susan G. Komen® 3:59 2 months ago 80 Скачать Далее
SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC ecancer 4:39 2 years ago 385 Скачать Далее
Treating ER+/HER2-low metastatic breast cancer, 2L and beyond COR2ED The Heart of Medical Education 11:22 4 months ago 5 561 Скачать Далее
Special Session: New Drug Approvals for Metastatic Breast Cancer San Antonio Breast Cancer Symposium 1:57:39 5 months ago 377 Скачать Далее
New Stage 4 Breast Cancer Cure? | Dr Liz O'Riordan Dr Liz O'Riordan 5:06 1 year ago 22 886 Скачать Далее